SPONSOR
National Health Research Institutes, Taiwan
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Primary Malignant Brain TumorsNon-small-cell Lung CancerMetastatic Gastric AdenocarcinomaSecond LineChemotherapyPrimary Melanoma of the ExtremityAdvanced Soft Tissue Sarcoma
National Health Research Institutes, Taiwan is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Primary Malignant Brain Tumors, Non-small-cell Lung Cancer, Metastatic Gastric Adenocarcinoma, Second Line.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Health Research Institutes, Taiwan
How many clinical trials has National Health Research Institutes, Taiwan sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by National Health Research Institutes, Taiwan, of which 5 are actively recruiting participants. These trials cover conditions including Primary Malignant Brain Tumors, Non-small-cell Lung Cancer, Metastatic Gastric Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Health Research Institutes, Taiwan research focus on?
National Health Research Institutes, Taiwan clinical trials span Primary Malignant Brain Tumors, Non-small-cell Lung Cancer, Metastatic Gastric Adenocarcinoma, Second Line, Chemotherapy, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Health Research Institutes, Taiwan clinical trial?
To participate in a National Health Research Institutes, Taiwan trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Health Research Institutes, Taiwan trials with current recruitment status updated daily.
Clinical Trials by National Health Research Institutes, Taiwan
NCT05622409
Recruiting
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
Primary Malignant Brain Tumors
NCT04849481
Recruiting
The Research Plan of Taiwan Precision Medicine
Non-small-cell Lung Cancer
NCT05927857 Phase 1, Phase 2
Recruiting
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
Metastatic Gastric Adenocarcinoma
NCT06952400
Recruiting
The Registry Study of Genetic Alterations of Melanoma in Taiwan
Primary Melanoma of the Extremity
NCT06981637 Phase 2
Recruiting
Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Advanced Soft Tissue Sarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology